B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis

BACKGROUND: Rituximab (RTX) may favorably affect skin and lung fibrosis in patients with systemic sclerosis (SSc); however, the underlying molecular mechanisms remain unknown. We aimed to explore the hypothesis that RTX may mediate its antifibrotic effects by regulating the expression of Dickkopf-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Daoussis, Dimitrios, Tsamandas, Athanassios, Antonopoulos, Ioannis, Filippopoulou, Alexandra, Papachristou, Dionysios J., Papachristou, Nicholaos I., Andonopoulos, Andrew P., Liossis, Stamatis-Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875588/
https://www.ncbi.nlm.nih.gov/pubmed/27208972
http://dx.doi.org/10.1186/s13075-016-1017-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875588/
https://www.ncbi.nlm.nih.gov/pubmed/27208972
http://dx.doi.org/10.1186/s13075-016-1017-y

Ejemplares similares